Abstract | PURPOSE: EXPERIMENTAL DESIGN: The in vitro effects of vandetanib were assessed in three ACC cell lines on cell growth, apoptosis, and VEGFR-2 and EGFR phosphorylation levels. The in vivo antitumor activity of vandetanib was examined in nude mice bearing parotid gland ACC tumors. The mice were treated for 4 weeks with vandetanib (50 mg/kg/d) or placebo (control). Tumors were resected at necropsy, and immunohistochemical and immunofluorescence staining were done. RESULTS: In vitro, vandetanib caused dose-dependent inhibition of VEGFR-2 and EGFR phosphorylation in ACC cells. Vandetanib also inhibited the cell proliferation and induced their dose-dependent apoptosis. In vivo, mice in the vandetanib group had tumor volumes significantly lower than those in the control group (P < 0.01). In addition, immunohistochemical staining showed a decrease in microvessel density and an increase in apoptosis of both tumor cells and endothelial cells within the tumor xenografts. CONCLUSION: These results suggest that vandetanib inhibits the growth of ACC in vitro and in vivo, making it a promising novel agent for the treatment of ACC.
|
Authors | Sungweon Choi, Daisuke Sano, Melvina Cheung, Mei Zhao, Samar A Jasser, Anderson J Ryan, Li Mao, Wan-Tao Chen, Adel K El-Naggar, Jeffrey N Myers |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 14
Issue 16
Pg. 5081-9
(Aug 15 2008)
ISSN: 1078-0432 [Print] United States |
PMID | 18698025
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Piperidines
- Quinazolines
- ErbB Receptors
- Vascular Endothelial Growth Factor Receptor-2
- vandetanib
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Blotting, Western
- Carcinoma, Adenoid Cystic
(drug therapy)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- ErbB Receptors
(drug effects)
- Fluorescent Antibody Technique
- Humans
- Immunohistochemistry
- In Situ Nick-End Labeling
- Male
- Mice
- Mice, Nude
- Parotid Neoplasms
(drug therapy)
- Phosphorylation
(drug effects)
- Piperidines
(pharmacology)
- Quinazolines
(pharmacology)
- Vascular Endothelial Growth Factor Receptor-2
(drug effects)
- Xenograft Model Antitumor Assays
|